Results Highlights

Highlights: FY2017 2Q Results (As of November 7, 2017)

  • Net sales: Increased
    • Solid overall sales performance across all businesses
    • Positive impact from the consolidation of CSP* in composites
      * Continental Structural Plastics Holdings Corporation: Became a consolidated subsidiary in January 2017
  • Operating income: Increased
    • Strong sales of aramid fibers and plastics
    • The upfront payment from Merck.*
      * The impact of licensing out of an investigational antibody candidate targeting tau for a possible new treatment of Alzheimer’s disease
  • Profit attributable to owners of parent: Increased
    • Due to increased operating income, and gain on sales of noncurrent assets

In the fiscal year 2017, March 31, 2018, consolidated net sales for the 1st half amounted to 404.7 billion yen, increased 51.6 billion yen compared with 353.0 billion yen for the 1st half of fiscal 2016. Operating income for the 1st half of fiscal 2017 were 37.5 billion yen, increased 10.5 billion yen compared with 27.0 billion yen for the 1st half of fiscal 2016. Ordinary income for the 1st half of fiscal 2017 amounted to 37.9 billion yen, increased 11.2 billion yen compared with 26.7 billion yen for the 1st half of fiscal 2016. Profit attributable to owners of parent of 29.2 billion yen for the 1st half of fiscal 2016 increased 7.8 billion yen compared with
21.4 billion yen in the 1st half of fiscal 2016.

Total assets as of September 30, 2017, amounted to 953.8 billion yen, down 10.2 billion yen from the end of fiscal 2016 (as of March 31, 2017, 964.1 billion yen). Shareholders´ equity was 383.2 billion yen, up 44.8 billion yen from the end of fiscal 2016 (as of March 31, 2017, 338.4 billion yen.) Interest-bearing debt was down 35.1 billion yen, from 376.2 billion yen at the end of fiscal 2016 to 341.1 billion yen.

* Profit attributable to owners of parent